Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Smith

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Vaccine|June 13, 2021
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health OrganizationMinal K Patel, Isabel Bergeri, Joseph S Bresee, et al.
BMJ Open|October 14, 2021
Integrating HIV, diabetes and hypertension services in Africa: study protocol for a cluster randomised trial in Tanzania and UgandaSayoki Godfrey Mfinanga, Moffat J Nyirenda, Gerald Mutungi, et al.
Lancet (London, England)|October 7, 2023
Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trialSokoine Kivuyo, Josephine Birungi, Joseph Okebe, et al.
Nature Medicine|February 20, 2018
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancersMichael Seiler, Akihide Yoshimi, Rachel Darman, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Cell Reports|November 14, 2015
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch PointRachel B Darman, Michael Seiler, Anant A Agrawal, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature|April 11, 2009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A Soucy, Peter G Smith, Michael A Milhollen, et al.
Cancer Cell|November 8, 2016
Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic LeukemiaLili Wang, Angela N Brooks, Jean Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2011
Subtype and pathway specific responses to anticancer compounds in breast cancerLaura M Heiser, Anguraj Sadanandam, Wen-Lin Kuo, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Vaccine|June 13, 2021
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health OrganizationMinal K Patel, Isabel Bergeri, Joseph S Bresee, et al.
BMJ Open|October 14, 2021
Integrating HIV, diabetes and hypertension services in Africa: study protocol for a cluster randomised trial in Tanzania and UgandaSayoki Godfrey Mfinanga, Moffat J Nyirenda, Gerald Mutungi, et al.
Lancet (London, England)|October 7, 2023
Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trialSokoine Kivuyo, Josephine Birungi, Joseph Okebe, et al.
Nature Medicine|February 20, 2018
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancersMichael Seiler, Akihide Yoshimi, Rachel Darman, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Cell Reports|November 14, 2015
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch PointRachel B Darman, Michael Seiler, Anant A Agrawal, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature|April 11, 2009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A Soucy, Peter G Smith, Michael A Milhollen, et al.
Cancer Cell|November 8, 2016
Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic LeukemiaLili Wang, Angela N Brooks, Jean Fan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2011
Subtype and pathway specific responses to anticancer compounds in breast cancerLaura M Heiser, Anguraj Sadanandam, Wen-Lin Kuo, et al.
Pageof 21